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LETTERS TO THE EDITOREFFECT OF RADIAL ARTERY
OR SAPHENOUS VEIN
CONDUITAS A SECOND GRAFT
ON LATE CLINICAL OUTCOME
AFTER CORONARYARTERY
BYPASS GRAFTING SURGERY
To the Editor:
We read with great interest the arti-
cle by Zacharias and colleagues1 re-
garding late outcomes after radial
artery (RA) versus saphenous vein
(SV) grafting during reoperative coro-
nary artery bypass surgery. We do not
support their statement that RA versus
SV grafting at reoperation was associ-
ated with a late survival benefit analo-
gous to what had been previously
reported by the same group2 when
the RA was used as a second arterial
conduit in primary coronary artery
bypass grafting (CABG) surgery.
In that article2 data analysis was per-
formed on a retrospective observa-
tional CABG series. The cumulative
0- to 6-year survival was better for
patients with RA conduits versus
propensity-matched patients with SVs
as a second conduit (925 patients in
each group). It might be reasonable to
assume that angiographic graft patency
influenced survival. However, the an-
giographic RA conduit’s patency
(1.8  1.4 years to redo angiographic
analysis) was 68.2%, which is statisti-
cally not better (P ¼ .11) than the SV
graft patency rate (63.3%). The au-
thors pointed out that patency compar-
ison derived from the subcohort of
restudied patients who received bothThe Editor welcomes submissions for possible publica-
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The JournalRA and SV conduits, in which each pa-
tient served as his or her own control
subject, has shown significantly better
RA graft patency (SV graft angio-
graphic failure rate of 41% vs
23.9% observed for RA conduits,
P ¼ .039)).2 Although we are discus-
sing a second conduit of choice in
a CABG cohort with an internal tho-
racic artery to the left anterior descend-
ing coronary artery (LAD), each
patient can serve as his or her own con-
trol subject only if tested conduits (RA
or SV) were randomly assigned to graft
either the circumflex or the right coro-
nary territory. Furthermore, target ves-
sel stenoses, diameters, and territories
of runoff (area of distribution) should
be similar and determined in inclusion
criteria. Although the authors are pro-
ponents of arterial grafting, we as-
sumed that RA conduits were placed
to the next best target other than the
LAD. If RA conduits were all applied
to the largest non-LAD target, the
cross-sectional area of their runoff cir-
culation would have been larger than
that of the SV grafts performed, which
could therefore be expected to failmore
readily than the RA grafts. Further-
more, when the SV grafts are used
only to the second-best target, patency
is 90% at 5 years on optional angio-
grams and 80% at 9 years in the
protocol-directed angiograms (pro-
spective, randomized, single-center
trial).3 Achouh and associates4 have re-
cently reported a similar angiographic
patency rate at 10 years after CABG
surgery for both conduits (83% of
RA conduits vs 81% of SV grafts).
Hayward and coworkers5 concluded
that use of the RA or SV for the second
conduit during primary CABG did not
significantly influence clinical out-
come at 6 years. There was no signifi-
cant difference in absolute survival in
the RA group versus that seen in the
SV group (similar number of patients,
16 deaths in each group, 4 deaths
were cardiac in cause in the RA group
vs 2 deaths in SV group). Unfortu-
nately, the cause of death is unknown
in the patient population of Zachariasof Thoracic and Cardiovascular Surgeand colleagues,1 and thus the death
rate might be independent of cardiac
factors.
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My coauthors and I reviewed the
letter by Nezic and colleagues1 related
to our recent article in the Journal.2 Al-
though we appreciate their opinion, we
were surprised that the letter at issue1
did not discuss our article2 per se.
Rather, it used our recent article as
a springboard to jump back to a 2004
article from our group,3 making essen-
tially the same point as in several pre-
vious letters that have discussed other
articles comparing the effects on late
coronary bypass surgery (CABG) out-
comes of use of radial artery (RA) ver-
sus saphenous vein (SV) as a second
grafting conduit. We stand by our
statement that the survival benefit
observed with RA versus SV graftingry c Volume 140, Number 4 941
Letters to the Editorafter reoperative CABG2 is indeed
analogous (or similar) to that we re-
ported previously after primary
CABG.3 In that respect, we believe
that the reported survival comparisons,
derived for a general cardiac surgical
population (as opposed to selected ran-
domized, controlled trials), are rather
self-explanatory and were based on
rigorous analyses applying propensity
modeling and matching methods.
Nezic and colleagues asserted that
the reported comparative RA and SV
patency data in the literature do not
support the contention that the ob-
served survival benefit is the result of
RA patency being superior to that of
SV.1 Here, we believe that it is appro-
priate to warn against an imbalanced
choice of cited literature. Specifically,
Nezic and colleagues1 cited only arti-
cles suggesting that RA and SV exhibit
similar late patency,4-6 ignoring any
other data that showed superior RA pa-
tency.7 Interestingly, no studies of su-
perior SV to RA patency were cited
in their letter. Also, any discussion of
SV graft durability should not ignore
the sobering SV patency results re-
ported in the PREVENT IV Trial.8 Fi-
nally, we do agree that providing
patency data that parallel the survival
data findings would be an important
addition to some of the survival analy-
ses reported by us and by others. At the
same time, we believe that rigorous
analyses showing, in the general car-
diac surgical population, compelling
data regarding the potential survival
advantagewhenRA is used as a second
arterial conduit in CABG should not be
glossed over.
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ANGIOGRAPHY TIMING, AND
ACUTE RENAL FAILURE
AFTER CORONARY
OPERATIONS
To the Editor:
We read with interest the recent arti-
cle of Medalion and coworkers titled
‘‘The Effect of Cardiac Angiography
Timing, Contrast Media Dose, and
Preoperative Renal Function on Acute
Renal Failure After Coronary Artery
Bypass Grafting.’’1 The authors found
that both high contrast dose at angiog-
raphy (>1.4 mL/kg), and an operation
done up to 5 days after angiography
were independent risk factors for post-
operative acute renal failure (ARF) in
patients who underwent coronary
artery bypass grafting.ardiovascular Surgery c October 2010The authors found partially differ-
ent results with respect to a similar
study that we published in 2008.2 In
that study, we identified that an opera-
tion done on the same day as the an-
giogram was an independent risk
factor for ARF after surgery. A high
contrast dose (>1.36 mL/kg) was
univariately but not independently
associated with ARF. Medalion and
coworkers1 hypothesized that this par-
tial discrepancy may result from the
dichotomization of the contrast dose
based on the median value (whereas
they used the upper quartile) and the
use of peak creatinine for the defini-
tion of ARF (peak creatinine twice
the baseline value and >2 mg/dL),
whereas they used a 25% decrease of
estimated creatinine clearance and cre-
atinine clearance of 60 mL/min or less
on day 3.
We think that the main difference
between the 2 studies is the definition
of ARF. Medalion and coworkers1
used a more liberal definition (stage 1
of the RIFLE [risk, injury, failure,
loss, end-stage kidney disease] crite-
ria)3 and ended up with a quite high
ARF rate (13.6%), whereas our defini-
tion was more restrictive (stage 2 of the
RIFLE criteria) and led to an ARF rate
of 5.7%. Of course, a multivariable
analysis with more events as the out-
come variable is more likely to accept
more independent variables. To check
for this hypothesis, we have reana-
lyzed our data using the same liberal
definition of ARF dichotomizing the
contrast dose at the upper quartile of
the distribution (1.7 mL/kg).
The results of this new analysis are
reported in Table 1. A high dose of
contrast agent is now an independent
risk factor for ARF. However, only
operations done on the same day as
the angiogram carry an independent
association with ARF. Therefore, the
discrepancy between our study and
the one of Medalion and coworkers1
remains, with respect to the ‘‘safe’’
time that should be applied between
the angiogram and the operation.
It is certain that contrast-induced
